Table 1.

Clinical Characteristics of Patients in the Study

	Adult	Aged	p-value
Number of patients	24	26
Age (y)	51 ± 2	74 ± 1	<.001
	(29–62)	(65–83)
Sex (male/female)	15/9	15/11	.59
BMI > 30	11 (48%)	7 (27%)	.20
Coronary artery disease	18 (78%)	24 (92%)	.18
History of MI	6 (26%)	6 (23%)	.81
Hypertension	14 (61%)	19 (73%)	.38
Hyperlipidemia	19 (83%)	20 (77%)	.63
Diabetes mellitus	0 (0%)	0 (0%)
Atrial fibrillation	0 (0%)	0 (0%)
History of smoking	16 (67%)	12 (46%)	.10
LA size < 4.5 cm	19 (68%)	21 (78%)	.42
LVEF (%)	63 ± 1	59 ± 2	.07
Beta blockers	16 (70%)	16 (62%)	.56
ACE/ARB inhibitors	11 (48%)	10 (39%)	.52
Calcium blockers	4 (17%)	5 (19%)	.87
Statins	15 (65%)	13 (50%)	.29
CABG	17 (74%)	23 (88%)	.21
AVR	3 (13%)	7 (27%)	.23
MVR	1 (4%)	3 (12%)	.75
Other	0 (0%)	1 (4%)

Note. Data are shown as the number of patients and percent of the total number in parenthesis n(%).. Age and left ventricular ejection fraction (LVEF) are presented as the mean ± SE. ACE I = angiotensin-converting enzyme inhibitors; AVR = aortic valve replacement; ARB = angiotensin II receptor antagonists; BMI = body mass index; CABG = coronary artery bypass grafting; MI = myocardial infarction; MVR = mitral valve replacement. Other surgery: aortic or septal myomectomy.